Umair Majeed

机构：Mayo Clinic in Florida · ORCID：0000-0002-4225-7555

发表论文 64 篇 · 总被引 791 次 · h-index 10

代表论文

• A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma (2024 · Annals of Oncology · 被引 38)
• Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma (2025 · Current Oncology · 被引 10)
• Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors (2025 · JAMA Network Open · 被引 7)
• Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials (2024 · Clinical and Experimental Gastroenterology · 被引 6)
• COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC (2024 · Future Oncology · 被引 4)
• Ipilimumab and nivolumab plus radioembolization as salvage therapy for atezolizumab and bevacizumab refractory hepatocellular carcinoma resulting in complete pathologic response (2024 · Radiology Case Reports · 被引 3)